EUR - EUROPEAN LITHIUM LIMITED
Investment Thesis
Asset: EUR's core assets are a ~31% CRML stake + 7.5% direct interest in Tanbreez HREE project (Greenland, 18km², eudialyte-hosted, low U/Th, 30-year exploitation licence) plus indirect exposure to CRML's Wolfsberg Lithium Project (Austria, DFS-complete, SK-1300 compliant resource) 🌍
What No One Else Is Seeing
Project Assessment
Asset: EUR's core assets are a ~31% CRML stake + 7.5% direct interest in Tanbreez HREE project (Greenland, 18km², eudialyte-hosted, low U/Th, 30-year exploitation licence) plus indirect exposure to CRML's Wolfsberg Lithium Project (Austria, DFS-complete, SK-1300 compliant resource) 🌍
Fair Value Assessment
The 137% premium to last uninterrupted close (A$0.245) sounds compelling, but EUR's intrinsic value was essentially a look-through discount on CRML — so the "premium" largely just closes that structural gap 🧮 At CRML US$11.86, the math works today, but you're accepting NASDAQ scrip risk: CRML is a pre-revenue critical minerals stock with its own volatility and liquidity profile
Key Concerns
Significant board overlap (3 Common Directors sit on both EUR and CRML boards) creates genuine conflicts; all-scrip deal means scheme value moves entirely with CRML's NASDAQ price before scheme completion; lithium price at US$1,200/t is deeply depressed, undermining Wolfsberg's near-term economics 🔴
WAIT
Not a placement — this is a corporate merger at a headline-attractive premium that mostly just removes a structural discount; hold if you already own EUR, but don't chase on-market at implied scheme value given CRML scrip execution risk and weak lithium fundamentals 🎯 📞 European Lithium Limited | +61 8 6181 9792 | info@europeanlithium.com
Valuation & Price Target
The 137% premium to last uninterrupted close (A$0.245) sounds compelling, but EUR's intrinsic value was essentially a look-through discount on CRML — so the "premium" largely just closes that structural gap 🧮 At CRML US$11.86, the math works today, but you're accepting NASDAQ scrip risk: CRML is a pre-revenue critical minerals stock with its own volatility and liquidity profile
Key Risks
Significant board overlap (3 Common Directors sit on both EUR and CRML boards) creates genuine conflicts; all-scrip deal means scheme value moves entirely with CRML's NASDAQ price before scheme completion; lithium price at US$1,200/t is deeply depressed, undermining Wolfsberg's near-term economics 🔴
Key Catalysts
| Date | Event |
|---|---|
| Near-term | Pending drill results / assays |
| Medium-term | Resource estimate update |
Not a placement — this is a corporate merger at a headline-attractive premium that mostly just removes a structural discount; hold if you already own EUR, but don't chase on-market at implied scheme value given CRML scrip execution risk and weak lithium fundamentals 🎯 📞 European Lithium Limited | +61 8 6181 9792 | info@europeanlithium.com
This report is prepared by Clubroom Research for informational purposes only. It does not constitute financial advice or a recommendation to buy, sell, or hold any security. All opinions and estimates are subject to change without notice. Always do your own research and consult a licensed financial adviser before making investment decisions. Past performance is not indicative of future results.
AI-Generated Analysis - This report was produced using Clubroom Stocks' proprietary AI engine, built on our own curated databases, custom training pipelines, and specialist prompting frameworks developed exclusively for ASX resource sector analysis. This is not financial advice. Always do your own research before making investment decisions.
Rating History — 30 alerts
All returns measured from alert price as Day 0
Day 1 = 1 trading day after alert. Day 5 = 5 trading days. Day 20 = 20 trading days. Live = current price vs alert price. Each alert tracks independently — a re-rating starts fresh tracking from the new alert price.